ࡱ> ;: g2ɀ\pEvans Gillian (Human Resources) Ba==xl)18X@"1Calibri1Calibri1Calibri1Calibri1Calibri1 Calibri1Calibri14Calibri1 Calibri1Calibri1Calibri1,8Calibri18Calibri18Calibri1>Calibri14Calibri1<Calibri1?Calibri1h8Cambria1Calibri1 Calibri1Arial18Arial""#,##0;\-""#,##0""#,##0;[Red]\-""#,##0""#,##0.00;\-""#,##0.00#""#,##0.00;[Red]\-""#,##0.005*0_-""* #,##0_-;\-""* #,##0_-;_-""* "-"_-;_-@_-,)'_-* #,##0_-;\-* #,##0_-;_-* "-"_-;_-@_-=,8_-""* #,##0.00_-;\-""* #,##0.00_-;_-""* "-"??_-;_-@_-4+/_-* #,##0.00_-;\-* #,##0.00_-;_-* "-"??_-;_-@_-"Yes";"Yes";"No""True";"True";"False""On";"On";"Off"],[$ -2]\ #,##0.00_);[Red]\([$ -2]\ #,##0.00\)                                                                       ff + ) , *     P  P        `            a>  8@ @  8@ @  ||@x>}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-}  00_)}-}  00_)}-}  00_)}-}  00_)}-}  00_)}-} 00_)}-} 00_)}A} 00_)ef[$ -}A} 00_)ef[$ -}A} 00_)ef[$ -}A} 00_)ef[$ -}A} 00_)ef[$ -}A} 00_)ef [$ -}A} 00_)L[$ -}A} 00_)L[$ -}A} 00_)L[$ -}A} 00_)L[$ -}A} 00_)L[$ -}A} 00_)L [$ -}A} 00_)23[$ -}A} 00_)23[$ -}A} 00_)23[$ -}A} 00_)23[$ -}A}  00_)23[$ -}A}! 00_)23 [$ -}A}" 00_)[$ -}A}# 00_)[$ -}A}$ 00_)[$ -}A}% 00_)[$ -}A}& 00_)[$ -}A}' 00_) [$ -}A}( 00_)[$ -}}) }00_)[$ -##0.  }}* 00_)[$ -???##0.??? ??? ???}-}+ 00_)}-}, 00_)}-}- 00_)}-}. 00_)}-}/ 00_)}A}0 a00_)[$ -}A}1 00_)[$ -}A}2 00_)?[$ -}A}3 00_)23[$ -}-}4 00_)}}5 ??v00_)̙[$ -##0.  }A}6 }00_)[$ -}A}7 e00_)[$ -}}8 00_)[$ -##0.  }}9 ???00_)[$ -???##0.??? ??? ???}-}: 00_)}-}; 00_)}U}< 00_)[$ -##0.}-}= 00_)}(}> 00_)}(}?  `00_) 20% - Accent1M 20% - Accent1 ef % 20% - Accent2M" 20% - Accent2 ef % 20% - Accent3M& 20% - Accent3 ef % 20% - Accent4M* 20% - Accent4 ef % 20% - Accent5M. 20% - Accent5 ef % 20% - Accent6M2 20% - Accent6  ef % 40% - Accent1M 40% - Accent1 L % 40% - Accent2M# 40% - Accent2 L渷 % 40% - Accent3M' 40% - Accent3 L % 40% - Accent4M+ 40% - Accent4 L % 40% - Accent5M/ 40% - Accent5 L % 40% - Accent6M3 40% - Accent6  Lմ % 60% - Accent1M 60% - Accent1 23 % 60% - Accent2M$ 60% - Accent2 23ږ % 60% - Accent3M( 60% - Accent3 23כ % 60% - Accent4M, 60% - Accent4 23 % 60% - Accent5M0 60% - Accent5 23 %! 60% - Accent6M4 60% - Accent6  23 % "Accent1AAccent1 O % #Accent2A!Accent2 PM % $Accent3A%Accent3 Y % %Accent4A)Accent4 d % &Accent5A-Accent5 K % 'Accent6A1Accent6  F %(Bad9Bad  %) Calculation Calculation  }% * Check Cell Check Cell  %????????? ???+ Comma,( Comma [0]-&Currency.. Currency [0]/Explanatory TextG5Explanatory Text % 0Good;Good  a%1 Heading 1G Heading 1 I}%O2 Heading 2G Heading 2 I}%?3 Heading 3G Heading 3 I}%234 Heading 49 Heading 4 I}% 5InputuInput ̙ ??v% 6 Linked CellK Linked Cell }% 7NeutralANeutral  e%3Normal % 8Noteb Note   9OutputwOutput  ???%????????? ???:$Percent ;Title1Title I}% <TotalMTotal %OO= Warning Text? Warning Text %XTableStyleMedium2PivotStyleLight16`71Response,8!Lucentis (Ranibizumab) Injections Avastin (Bevacizumab) InjectionsEylea (Aflibercept) Injections Illuvieb (Fluocinolone) ImplantsOzudex (Dexamethasone) Implants+Wet Age Related Macular Degeneration (wAMD)Diabetic Macualr Oedema (DMO)9Retinal Vein Occlusion  Central or Branch (CRVO or BRVO) Other eg mCNV3463541594918521495241/ q0|0ccB g2ɀ _OQ  dMbP?_*+%,&ffffff?'ffffff?(?)?M\\wwlxerps1\Xerox_Follow_You0C 4dXXA4 (210 x 297 mm)DINU"D~SMTJXerox PullPrn PCL6 V4.0.548.8.0RESDLLUniresDLLXrxTrueTypeFontDlOptionTTF_DOWNLOAD_AS_TRUETYPEXrxEdgeToEdgeEDGE_TO_EDGE_OFFColorMode24bppXrxHalftoneXRX_NORMAL_HTXEROX_JOB_SETUP_BEGINCBXEROX_JOB_SETUP_ENDCBXEROX_DOC_BEGINCBXEROX_DOC_SETUP_ENDCBXEROX_PAGE_SETUP_BEGINCBXEROX_PAGE_SETUP_ENDCBXEROX_PAGE_FINISH_BEGINCBXEROX_PAGE_FINISH_ENDCBXEROX_DOC_FINISH_BEGINCBXEROX_DOC_FINISH_ENDCBXEROX_JOB_FINISH_BEGINCBXEROX_JOB_FINISH_ENDCBOrientationPORTRAITCollateONDuplexVERTICALResolutionRes600x600PaperSizeA4D1NRX .l   MSCF,90R)//Uncompressed-Data//:}4)CKZklU>;---:.ІBA!/lQ`i Jc01?D,呠DHDh^߹gv];oΙ͹sgekv+AʗVT%[!HK`]Mglڑn|ƫiFYI/k%,>+_d>$mݏ 'X7Eo-н-wԽ4搨g)g!Y}$Q wvD6>+83&'0Lp&/a"sU/0G`M3 y߳˶-<-p898 O '?sMh>ճz6B+CdjکZRm<-Gp ¡ٵxQnk ث3,q5b>Gsԉ根=Zl\H[],PRn )2y,V<ɂw\V :oYdȶ*k&󭃁DVh؝]7_YN ~G%y( ~&msd'mM1cXp5]k~5]OJ4bT֐uh̯^-~vJ|ȕDt&Lc7L1_v]f[|̸ȣJR6"s:x rh4W %LlFūPŹ_J4v,Q)yej|`>KV1qKƐ6kX^>o%13 }I-JWj'ή̫T.Uczg2>Un#ᵁܪ e9+D:A]{ZʭM*/ ?+c$!6czc7Q*hQ-׫"?Č[)_J+p12ǫ偷Y8s^#,:5ŵ%!Q(u(%y:DqCAuy}favTW^f!KPC:TuTw:D&ס1Au;l"PZPb^[ȃsS&!űݭ*ťx SucTUuyiv&x ر i1DKT`Zumx4~mTɹhPv(M@8:.Oз39-ݸY' -VLٟ4p]mFaw/(vaٝpHR4[GXväNyi{BمiBy!-]sH eWCZ5 > > > > > > ? ~ ? ? ?? > ? ~ ? ? ? ~ ? > ? ? ??? > ?~ ? ???PPNTN>@?:  ggD Oh+'0@Hp  Evans Gillian (Human Resources) Evans Gillian (Human Resources)Microsoft Excel@z@/ym՜.+,0 PXd lt| WWL  Response  Worksheets  !"#$%&'()+,-./013456789Root Entry FWorkbook7RSummaryInformation(*DocumentSummaryInformation82